FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001066017 Concept inactivation indicator attribute value reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001067014 Concept inactivation indicator reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001068016 Concept inactivation indicator attribute value reference set (foundation metadata concept) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


141007 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Concept inactivation indicator reference set Is a Attribute value type true Inferred relationship Some

Members valueId
Cinnarizine [nausea] A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cinnarizine [vasodilator] A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cip-fenofibrate A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ciprofloxacin 0.2% + hydrocortisone 1% otic solution A component that is no longer current, useful, appropriate or acceptable.
Ciprofloxacin 0.3% + dexamethasone 0.1% sterile otic suspension Ambiguous
Ciprofloxacin 1% injection A component that fails to comply with the current editorial guidance.
Ciprofloxacin 1000mg m/r tablet A component that is no longer current, useful, appropriate or acceptable.
Ciprofloxacin 1000mg prolonged-release oral tablet A component that is no longer current, useful, appropriate or acceptable.
Ciprofloxacin 10g/100mL oral suspension A component that is no longer current, useful, appropriate or acceptable.
Ciprofloxacin 10mg/mL (1%) injection solution 20mL vial A component that fails to comply with the current editorial guidance.
Ciprofloxacin 10mg/mL (1%) injection solution 40mL vial A component that fails to comply with the current editorial guidance.
Ciprofloxacin 1200mg solution A component that fails to comply with the current editorial guidance.
Ciprofloxacin 200mg solution A component that is no longer current, useful, appropriate or acceptable.
Ciprofloxacin 200mg/100mL A component that is no longer current, useful, appropriate or acceptable.
Ciprofloxacin 200mg/100mL intravenous injection solution 100mL premixed bag A component that is no longer current, useful, appropriate or acceptable.
Ciprofloxacin 200mg/bag injection A component that is no longer current, useful, appropriate or acceptable.
Ciprofloxacin 200mg/vial injection A component that fails to comply with the current editorial guidance.
Ciprofloxacin 200mg/vial injection solution 20mL vial A component that fails to comply with the current editorial guidance.
Ciprofloxacin 2mg/mL A component that is no longer current, useful, appropriate or acceptable.
Ciprofloxacin 2mg/mL infusion solution 100mL bottle A component that fails to comply with the current editorial guidance.
Ciprofloxacin 2mg/mL infusion solution 200mL bottle A component that is no longer current, useful, appropriate or acceptable.
Ciprofloxacin 2mg/mL infusion solution 50mL bottle A component that is no longer current, useful, appropriate or acceptable.
Ciprofloxacin 400mg solution A component that fails to comply with the current editorial guidance.
Ciprofloxacin 400mg/200mL intravenous injection solution 200mL premixed bag A component that fails to comply with the current editorial guidance.
Ciprofloxacin 400mg/bag injection A component that fails to comply with the current editorial guidance.
Ciprofloxacin 400mg/vial injection A component that fails to comply with the current editorial guidance.
Ciprofloxacin 400mg/vial injection solution 40mL vial A component that fails to comply with the current editorial guidance.
Ciprofloxacin 500mg m/r tablet A component that is no longer current, useful, appropriate or acceptable.
Ciprofloxacin 500mg prolonged-release oral tablet A component that is no longer current, useful, appropriate or acceptable.
Ciprofloxacin 5g/100mL suspension A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ciprofloxacin [eye] A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension A component that is no longer current, useful, appropriate or acceptable.
Ciprofloxacin hydrochloride 0.3% solution A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ciprofloxacin hydrochloride 3.5mg solution A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Ciprofloxacin+hydrocortisone Ambiguous
Circadian rhythm study Ambiguous
Circle of Willis and its branches Ambiguous
Circling gait Ambiguous
Circular layer of muscularis propria of anal canal A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Circulating fluid whole body heating/cooling pad system, single-use Ambiguous
Circulation maintenance A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Circulatory assist transseptal cannulation set A component that fails to comply with the current editorial guidance.
Circulatory function test NOS Classification derived component
Circulatory function test NOS Classification derived component
Circulatory function tests (& [blood flow]) Ambiguous
Circulatory function tests (& [blood flow]) Ambiguous
Circulatory stress test A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Circulatory system anomaly NOS Limited component (foundation metadata concept)
Circulatory system disease NOS Ambiguous
Circulatory system disease NOS Ambiguous
Circulatory system disease NOS Ambiguous
Circulatory time A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Circulatory topical preparations A component that fails to comply with the current editorial guidance.
Circumcision A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Circumcision clamp, reusable Ambiguous
Circumcision clamp, single-use Ambiguous
Circumcision kit, reusable A component that fails to comply with the current editorial guidance.
Circumcision kit, single-use A component that fails to comply with the current editorial guidance.
Circumcision requested A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Circumference measurements A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Circumference measurements A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Circumferential Ambiguous
Circumflex femoral artery - medial and its branches Ambiguous
Circumoral muscle Ambiguous
Circumpapillary dystrophy of choroid A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Circumscribed alopecia A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Circumscribed labyrinthitis A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Circumscribed scleroderma NOS Classification derived component
Circumscribed tumor configuration A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cirit horse breed Moved elsewhere
Cirneco dell'Etna dog breed Moved elsewhere
Cirrhosis - non-alcoholic A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cirrhosis and chronic liver disease Ambiguous
Cirrhosis of liver NOS Limited component (foundation metadata concept)
Cirrhosis of liver not due to alcohol A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cirrhosis of liver: [multilobular portal] or [postnecrotic] Ambiguous
Cirrhosis secondary to cholestasis A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cirrhosis: [cardiac portal] or [congestive] Ambiguous
Cirrhosis: [florid] or [alcoholic] Ambiguous
Cirrhosis: [juvenile portal] or [childhood function] or [Indian childhood] Ambiguous
Cisapride 1mg/mL suspension A component that is no longer current, useful, appropriate or acceptable.
Cisapride overdose of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cisapride poisoning of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cisatracurium 20mg/10mL injection Ambiguous
Cisatracurium 2mg/mL injection solution 2.5mL ampule Ambiguous
Cisatracurium 2mg/mL injection solution 5mL ampule Ambiguous
Cisatracurium 5mg/mL injection solution 30mL ampule A component that fails to comply with the current editorial guidance.
Cisatracurium besylate A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Cisatracurium besylate 10mg/mL injection solution ampule Ambiguous
Cisatracurium besylate 20mg injection Ambiguous
Cisatracurium besylate 20mg/10mL injection Ambiguous
Cisatracurium besylate 2mg/mL injection solution 10 mL ampule A component that fails to comply with the current editorial guidance.
Cisatracurium besylate 2mg/mL injection solution 10mL vial Ambiguous
Cisatracurium besylate 2mg/mL injection solution 2.5 mL ampule A component that fails to comply with the current editorial guidance.
Cisatracurium besylate 2mg/mL injection solution 5 mL ampule A component that fails to comply with the current editorial guidance.
Cisatracurium besylate 2mg/mL injection solution ampule A component that fails to comply with the current editorial guidance.
Cisplatin 100mg/vial injection A component that fails to comply with the current editorial guidance.
Cisplatin 100mg/vial injection solution A component that fails to comply with the current editorial guidance.
Cisplatin 100mg/vial powder for injection A component that fails to comply with the current editorial guidance.
Cisplatin 10mg/vial injection A component that fails to comply with the current editorial guidance.
Cisplatin 10mg/vial powder A component that fails to comply with the current editorial guidance.

Start Previous Page 260 of 1411 Next End


Reference Sets

Reference set descriptor

Back to Start